Contribution of 18Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung …

ZD Kanmaz, G Aras, E Tuncay, A Bahadır… - Cancer …, 2016 - content.iospress.com
AIM: The aim of this study is to evaluate the diagnostic value of PET-CT scan for the
prediction of EGFR mutation status and the contribution of TTF-1 expression to PET-CT …
被引用次数：24 相关文章 所有 5 个版本
[PDF] wiley.comFull View

Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung …

L Zhu, G Yin, W Chen, X Li, X Yu, X Zhu… - Thoracic …, 2019 - Wiley Online Library
Background The purpose of this study was to investigate an association between EGFR
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …
被引用次数：20 相关文章 所有 7 个版本

Value of 18F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma

KH Ko, HH Hsu, TW Huang, HW Gao… - European journal of …, 2014 - Springer
Purpose The identification of the mutation status of the epidermal growth factor receptor
(EGFR) is important for the optimization of treatment in patients with pulmonary …
被引用次数：73 相关文章 所有 14 个版本
[HTML] nih.gov

[HTML][HTML] The predictive value of 18F-FDG PET/CT in an EGFR-mutated lung adenocarcinoma population

J Wang, X Wen, G Yang, Y Cui, M Hao… - Translational Cancer …, 2022 - ncbi.nlm.nih.gov
Background A non-invasive, simple, and convenient method to evaluate the presence of
epidermal growth factor receptor (EGFR) mutations is important for initial treatment decisions …
被引用次数：2 相关文章 所有 6 个版本
[PDF] springer.com

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations

X Wumener, Y Zhang, Z Zang, F Du, X Ye… - BMC Pulmonary …, 2024 - Springer
Abstract Objectives 18F-fluorodeoxyglucose (FDG) PET/CT has been widely used for the
differential diagnosis of cancer. Semi-quantitative standardized uptake value (SUV) is …
被引用次数：1 相关文章 所有 2 个版本
[HTML] nih.gov

[HTML][HTML] 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiomic features for prediction of epidermal growth factor receptor …

B Yang, HS Ji, CS Zhou, H Dong, L Ma… - Translational Lung …, 2020 - ncbi.nlm.nih.gov
Background To investigate whether radiomic features from (18 F)-fluorodeoxyglucose
positron emission tomography/computed tomography [(18 F)-FDG PET/CT] can predict …
被引用次数：23 相关文章 所有 7 个版本

Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT

M Jiang, Y Zhang, J Xu, M Ji, Y Guo… - Nuclear medicine …, 2019 - journals.lww.com
Objective The aim of this study was to investigate whether quantitative and qualitative
features extracted from PET/computed tomography (CT) can be used as imaging biomarkers …
被引用次数：35 相关文章 所有 3 个版本
[PDF] academia.edu

Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma

CT Huang, RF Yen, MF Cheng, YC Hsu, PF Wei… - Medical Oncology, 2010 - Springer
Objective Epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma are
involved in the tumorigenesis and regulation of cell metabolism via Akt signaling. F-18 …
被引用次数：81 相关文章 所有 12 个版本
[HTML] frontiersin.org

[HTML][HTML] Correlations Study Between 18F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung …

B Yang, QG Wang, M Lu, Y Ge, YJ Zheng, H Zhu… - Frontiers in …, 2019 - frontiersin.org
Purpose: This study assessed the ability of metabolic parameters from
18Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG …
被引用次数：20 相关文章 所有 6 个版本
[HTML] nih.gov

[HTML][HTML] Value of combining PET/CT and clinicopathological features in predicting EGFR mutation in Lung Adenocarcinoma with Bone Metastasis

G Yao, Y Zhou, Y Gu, Z Wang, M Yang, J Sun… - Journal of …, 2020 - ncbi.nlm.nih.gov
Purpose: Epidermal growth factor receptor (EGFR) mutation is the most common target for
precision treatment in metastatic lung adenocarcinoma. We investigated the predictive role …
被引用次数：13 相关文章 所有 8 个版本